Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03891654 · ClinicalTrials.gov registry record · Early Phase 1

Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients

A Early Phase 1 study, sponsored by University of Colorado, Denver.

Completed
Registry status
Early Phase 1
Development phase
3
Enrollment target

NCT03891654: Completed Early Phase 1 study, sponsored by University of Colorado, Denver.

NCT03891654 is a Early Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 3 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03891654, a Early Phase 1 study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
Early Phase 1
Development phase
3 participants
Enrollment target

Study Summary

This is a pilot study that uses a standard of care technique, Stereotactic Body Radiation Therapy (SBRT), in combination with Dynamic Contrast Enhanced Computed Tomography (DCE-CT) to determine if perfusion changes from SBRT of liver cancer may be used for outcome assessment and prediction of prognosis.

Primary Outcome

Determine the association between the delivered radiation therapy dose distribution and the change in perfusion measurement through K-Trans (extraction-flow product) as shown through DCE-CT imaging.

Interventions

  • DIAGNOSTIC_TEST Dynamic Contrast Enhanced Computed Tomography

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2019-08-01
Est. Completion 2022-04-28
Phase Early Phase 1
University of Colorado, Denver

1,283 total trials

What the finished NCT03891654 record still lists

NCT03891654 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which Dynamic Contrast Enhanced Computed Tomography is the first listed.

NCT03891654 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03891654 about?

NCT03891654 is a clinical study titled "Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients". This is a pilot study that uses a standard of care technique, Stereotactic Body Radiation Therapy (SBRT), in combination with Dynamic Contrast Enhanced Computed Tomography (DCE-CT) to determine if perfusion changes from SBRT of liver cancer may be used for outcome assessment and prediction of progno...

What is the current status of trial NCT03891654?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2019-08-01. Estimated completion is 2022-04-28.

What interventions are being tested in trial NCT03891654?

The interventions under investigation include: Dynamic Contrast Enhanced Computed Tomography (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03891654?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03891654's enrollment target sits among peer trials

3 1949th of 2000 higher than 28 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03891654, the US trial registry maintained by the National Library of Medicine. NCT03891654 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.